Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study

被引：0
|
作者：
Smolen, Josef S. [1 ,2 ]
van Vollenhoven, Ronald [3 ]
Kavanaugh, Arthur [4 ]
Strand, Vibeke [5 ]
Vencovsky, Jiri [6 ]
Schiff, Michael H. [7 ]
Landewe, Robert [8 ,9 ]
Haraoui, Boulos [10 ]
Walker, Susan [11 ]
van der Heijde, Desiree [12 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Hietzing Hosp, Vienna, Austria
[3] Karolinska Inst, Stockholm, Sweden
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Stanford Univ, Palo Alto, CA 94304 USA
[6] Charles Univ Prague, Dept Clin & Expt Rheumatol, Inst Rheumatol, Fac Med 1, Prague, Czech Republic
[7] Univ Colorado, Denver, CO 80202 USA
[8] Acad Med Ctr Amsterdam, Heerlen, Netherlands
[9] Atrium Med Ctr, Heerlen, Netherlands
[10] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[11] UCB Pharma, Raleigh, NC USA
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2321
引用
收藏
页码：S988 / S989
页数：2
相关论文
共 50 条
  • [41] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [42] LONG-TERM (156-WEEK) EFFICACY AND SAFETY PROFILE OF ORAL APREMILAST FOR PSORIATIC ARTHRITIS: RESULTS FROM THE PALACE 1 PHASE III, RANDOMIZED, CONTROLLED TRIAL AND OPEN-LABEL EXTENSION
    Kavanaugh, A.
    Gladman, D. D.
    Gomez-Reino, U.
    Hall, S.
    Lespessailles, E.
    Mease, P. J.
    Schett, G.
    Mcllraith, M.
    Shah, K.
    Teng, L.
    Wollenhaupt, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 758 - 758
  • [43] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [44] Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study
    Taylor, P.
    Genovese, M.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    Lundmark, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 59 - 59
  • [45] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, P.
    Genovese, M. C.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 66
  • [46] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, Peter
    Genovese, Mark
    Keystone, Ed
    Schlichting, Douglas
    Beattie, Scott
    Macias, William
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A31 - A31
  • [47] Analysis of Pooled Data from Two Randomized Controlled Trials and Their Open-Label Extensions: Long-Term Safety in Rheumatoid Arthritis before and after Certolizumab Pegol Dose Increase/Decrease
    Haraoui, Boulos
    Bykerk, Vivian P.
    van Vollenhoven, Ronald
    de Longueville, Marc
    Luijtens, Kristel
    Ralston, Pauline
    Kavanaugh, Arthur
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S199 - S199
  • [48] Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study
    Bussel, James B.
    Kuter, David J.
    Newland, Adrian
    de Wolf, Joost T. M.
    Wasser, Jeffrey
    Chang, Paul
    Nie, Kun
    Berger, Dietmar
    BLOOD, 2009, 114 (22) : 285 - 285
  • [49] Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis
    Klareskog, L.
    Gaubitz, M.
    Rodriguez-Valverde, V.
    Malaise, M.
    Dougados, M.
    Wajdula, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 238 - 247
  • [50] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
    Cutler, Andrew J.
    Kalali, Amir H.
    Mattingly, Greg W.
    Kunovac, Jelena
    Meng, Xiangyi
    CNS SPECTRUMS, 2013, 18 (01) : 43 - 54
12345